November 2016

Curative Regenerative Medicines: Preparing Health Care Systems For The Coming Wave

In Vivo
Michael J. Werner | Faraz Ali | Ted Slocomb

We may be at the dawn of a new era of curative regenerative therapies, but their inherent nature may create barriers to adoption. The Alliance for Regenerative Medicine frames the opportunities and challenges for the industry, arguing that policy makers must begin to understand the ways that these therapies represent value for money.

READ: Curative Regenerative Medicines: Preparing Health Care Systems For The Coming Wave

Related Insights